News|Articles|August 1, 2024
Scalable Solutions for Novel Oral Solid Dose Development and Manufacturing
Author(s)Alcami
Developing successful oral solid dosage forms necessitates partnering with a CDMO equipped with distinctive technologies and expertise to enable support across solid-state characterization, formulation development and scale-up manufacturing processes.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
AI, CRISPR, and mRNA Driving Biotech’s Smartest Decade Yet
2
Top 10 BioPharm International Articles of 2025
3
FAQ: Understanding Biosimilars, Biobetters, and Interchangeability
4
Integrated Platform Eliminates Ex-Vivo Expansion Barrier for CAR-T Access
5